ISSN:

Journal Home

Lung Cancer: Targets and Therapy Q1 Unclaimed

Dove Medical Press Ltd. New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Lung Cancer: Targets and Therapy is a journal indexed in SJR in Oncology with an H index of 29. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on lung cancer, palliative care, cancer screening. It has an SJR impact factor of 1,415 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,415.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (Q1)

Price

1602 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,415

SJR Impact factor

29

H Index

19

Total Docs (Last Year)

34

Total Docs (3 years)

608

Total Refs

149

Total Cites (3 years)

26

Citable Docs (3 years)

3.4

Cites/Doc (2 years)

32.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
JAMA oncology Q1
Journal of Thoracic Oncology Q1
Cancer Discovery Q1
Neuro-Oncology Q1

Compare this journals

Aims and Scope

Lung cancer Palliative care Cancer screening